From the biology of aging to the future of artificial intelligence (AI)-driven medicine, Mount Sinai Health System is set to participate at the 2025 Aspen Ideas: Health. The event runs from Sunday, June 22 through to Wednesday, June 25. In addition, key information will be shared at the Aspen Ideas Festival (June 25 to Tuesday, July 1) running in Aspen, Colorado.
As well as Mount Sinai thought leaders leading discussions, the Health System will provide complimentary dermatologic screenings for attendees. Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with 48,000 employees working across seven hospitals.
“We return to Aspen Ideas: Health and the Aspen Ideas Festival deeply inspired—by the setting, the community, and the shared pursuit of progress,” Brendan G. Carr has told Digital Journal.
“This year, my colleagues will explore the emerging science of aging and inflammation and how Mount Sinai is harnessing AI to propel science and health care innovation. Our goal, as a learning health system, is to solve the world’s most complex health and science challenges to improve health of people everywhere.”
Carr will moderate the panel “Living Better, Longer: The New Science of Healthspan” on Tuesday, June 24, 10:20 am to 11:10 am (MDT) in the East Lawn Tent. The conversation will centre on the intricate mechanisms behind aging—from cellular health and genetic risk to current medical and technological solutions—that shed light on inflammaging, the chronic inflammation that accelerates age-related decline.
Key mechanisms involved in aging include DNA damage and instability, telomere shortening, epigenetic alterations, and mitochondrial dysfunction. These changes contribute to cellular senescence, stem cell exhaustion, and altered intercellular communication, ultimately leading to a decline in overall function and increased susceptibility to age-related diseases.
The panellists will discuss advances in immune resilience, regenerative medicine, and neurosurgical and genetic interventions that could hold the keys to a future where we can all live longer, healthier, and more optimized lives.
Panellists from the Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai, include:
- Zahi Fayad, PhD, Founding Director of the Biomedical Engineering and Imaging Institute; Vice Chair for Research, Department of Diagnostic, Molecular, and Interventional Radiology; Lucy G. Moses Professor of Medical Engineering and Bioengineering.
- Brian Kopell, MD, Director of the Center for Neuromodulation; Co-Director, The Bonnie and Tom Strauss Center for Movement Disorders; Professor of Neurosurgery, Neurology, Psychiatry, and Neuroscience.
- Sarah Millar, PhD, Director of the Institute for Regenerative Medicine and the Black Family Stem Cell Institute; Dean for Basic Science; and Lillian and Henry M. Stratton Professor of Gene and Cell Medicine.
- Sanjai Sinha, MD, Associate Professor of Clinical Medicine and an attending physician at The Health Center at Hudson Yards.
Mount Sinai will also host the panel “Intelligence at the Edge: Reimagining and Propelling Health Care with AI.” Here, the panellists will discuss how AI is transforming health care for patients and providers.
As the first academic medical system to launch a Department of AI and Human Health, Mount Sinai is building a learning health system that leverages diverse data—genomics, health records, and clinical, social and environmental data—to inform decisions that prevent disease, optimize health, and improve outcomes.
